Laminar Therapeutics Stock Is Popping Today: What's Going On?

Benzinga_recent_news02-26 03:30

Larimar Therapeutics Inc (NASDAQ:LRMR) shares are jumping on Wednesday after multiple analysts reiterated their bullish outlook. Citigroup's Samantha Semenkow kept her Buy rating and raised her price ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614058291?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Candlestick-Graph-Chart-Of-Stock-And-For_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-02-26 03:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614058291","market":"sh","top_or_hot":-1,"title":"Laminar Therapeutics Stock Is Popping Today: What's Going On?","media":"Benzinga_recent_news","content":"<div>\n<p>Larimar Therapeutics Inc (NASDAQ:LRMR) shares are jumping on Wednesday after multiple analysts reiterated their bullish outlook.\nCitigroup's Samantha Semenkow kept her Buy rating and raised her price ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/02/50864109/laminar-therapeutics-stock-is-popping-today-whats-going-on\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Laminar Therapeutics Stock Is Popping Today: What's Going On?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLaminar Therapeutics Stock Is Popping Today: What's Going On?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-26 03:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/26/02/50864109/laminar-therapeutics-stock-is-popping-today-whats-going-on><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Larimar Therapeutics Inc (NASDAQ:LRMR) shares are jumping on Wednesday after multiple analysts reiterated their bullish outlook.\nCitigroup's Samantha Semenkow kept her Buy rating and raised her price ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/02/50864109/laminar-therapeutics-stock-is-popping-today-whats-going-on\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50864109/laminar-therapeutics-stock-is-popping-today-whats-going-on","article_id":"2614058291","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Candlestick-Graph-Chart-Of-Stock-And-For_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50864109/laminar-therapeutics-stock-is-popping-today-whats-going-on","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614058291","pubTimestamp":1772047800,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Larimar Therapeutics Inc (NASDAQ:LRMR) shares are soaring on Wednesday after multiple analysts reiterated their bullish outlook.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技","LENZ":"Therapeutics","BK4007":"制药","LRMR":"Larimar Therapeutics, Inc."},"translate_title":"Laminar Therapeutics股票今天上涨：发生了什么？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1.5,"LRMR":1},"content_text":"Larimar Therapeutics Inc (NASDAQ:LRMR) shares are jumping on Wednesday after multiple analysts reiterated their bullish outlook.\nCitigroup's Samantha Semenkow kept her Buy rating and raised her price target from $12 to $14, and Wedbush's Laura Chico reaffirmed her Outperform rating with an $11 target.\nOver the past year, Larimar has seen an impressive 106.15% increase in its stock price, reflecting strong investor confidence. Currently, the stock is trading well above its key moving averages, with a 72.5% lead over the 50-day SMA and a 62.6% lead over the 100-day SMA. These indicators underscore a robust upward trend in the stock’s performance.\nThe technical indicators further support this bullish sentiment. The RSI stands at 58.66, indicating that the stock is neither overbought nor oversold, while the MACD, which is above its signal line, suggests continued bullish momentum. These factors combined paint a picture of sustained positive momentum for Larimar.\nDespite a slight pullback in the broader Healthcare sector today, Larimar Therapeutics is standing out in a major way, soaring more than 72%. While the sector as a whole is down 0.11% and ranks sixth out of eleven in market performance, Larimar is moving in the opposite direction with remarkable strength. Its surge sharply contrasts the sector's weakness, underscoring just how dramatically the company is outperforming its peers today.\nBelow is the Benzinga Edge scorecard for Larimar Therapeutics, highlighting its strengths and weaknesses compared to the broader market:\nThe Verdict: Larimar Therapeutics’ Benzinga Edge signal reveals a company with moderate momentum, reflecting its recent positive developments and market performance. Investors should consider both the potential for continued growth driven by its innovative treatments and the inherent risks typical of the biotech sector.\nLRMR Price Action: Larimar shares were up 67.21% at $6.17 at the time of publication on Wednesday. The stock is trading at a new 52-week high, according to Benzinga Pro.\nImage: Vintage Tone/Shutterstock.com\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614058291","isCrawlerRequest":true}